Apolipoprotein C-II Antikörper (HRP)
Kurzübersicht für Apolipoprotein C-II Antikörper (HRP) (ABIN7449301)
Target
Alle Apolipoprotein C-II (APOC2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- Goat anti-Human Apo CII [H08] Antibody HRP Conjugated
-
Immunogen
- Human Apolipoprotein CII
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB: 1:1,000 - 1:4,000
ELISA: 1:1,000 - 1:4,000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1 mg/mL
-
Buffer
- 50 mM PBS, 0.1 M NaCl, and 0.01 % Thiomersal, pH 7.4
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Haltbarkeit
- 12 months
-
-
- Apolipoprotein C-II (APOC2)
-
Andere Bezeichnung
- ApoCII
-
Hintergrund
- Background: ApoCII contains 78 amino acid residues. The m.w. is 8.5 kDa (Jackson et al., 1977). The lipid-binding domain of Apo CII is localized to a region in the N-terminal with a strongly amphipathic nature (Macphee et al., 1999). Apo CII is also one of the key components of the metabolism of total triacylglycerol-rich lipoproteins by activating lipoprotein lipase that hydrolyzes fatty acids from triacylglycerols in chylomicrons. (Kei et al., 2012)
-
Gen-ID
- 344
-
NCBI Accession
- NP_000474
-
UniProt
- P02655
-
Pathways
- Lipid Metabolism
Target
-